XML 89 R75.htm IDEA: XBRL DOCUMENT v3.25.0.1
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)
12 Months Ended
Sep. 16, 2024
USD ($)
Dec. 31, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2013
USD ($)
Goodwill [Line Items]              
Number of operating segments | segment   2          
Number of reporting units | segment   3          
Goodwill   $ 59,990,000 $ 28,221,000        
Goodwill, impairment loss   0 0 $ 0      
Intangible assets acquired     9,600,000        
Intangible asset impairment charge   3,600,000 0 100,000      
Amortization of intangible assets   60,300,000 52,300,000 49,500,000      
Impairment of intangible assets, indefinite-lived   4,000,000.0 0 $ 0      
Increase (decrease) in definite-lived intangible assets     16,400,000        
Finite-lived intangible gross carrying amount   $ 893,825,000 496,708,000        
Maximum              
Goodwill [Line Items]              
Remaining estimated useful lives   12 years          
Acquired ANDA intangible assets              
Goodwill [Line Items]              
Finite-lived intangible gross carrying amount   $ 210,497,000 209,780,000        
Acquired ANDA intangible assets | Slayback Pharma Limited Liability Company and Akorn Holding Company              
Goodwill [Line Items]              
Intangible assets acquired     7,100,000        
Acquired ANDA intangible assets | Reclassification of Assets on Completion of Project and Launch of Related Products | In process research and development              
Goodwill [Line Items]              
Finite-lived intangible gross carrying amount     6,800,000        
Product Rights | Alvogen Inc              
Goodwill [Line Items]              
Intangible assets acquired     $ 2,000,000.0        
BioSante Pharmaceuticals              
Goodwill [Line Items]              
Acquisition of goodwill             $ 1,800,000
WellSpring              
Goodwill [Line Items]              
Acquisition of goodwill           $ 1,700,000  
Novitium              
Goodwill [Line Items]              
Acquisition of goodwill         $ 24,600,000    
Alimera Sciences, Inc              
Goodwill [Line Items]              
Goodwill $ 32,202,000 31,765,000          
Alimera Sciences, Inc | YUTIQ              
Goodwill [Line Items]              
Intangible assets acquired $ 170,000 170,000,000.0          
Remaining estimated useful lives 12 years            
Alimera Sciences, Inc | ILUVIEN              
Goodwill [Line Items]              
Intangible assets acquired $ 230,000 $ 230,000,000.0          
Remaining estimated useful lives 12 years